Incidence and prevalence of multiple sclerosis in Spain: a systematic review F.J. García López; A. García-Merino; E. Alcalde-Cabero; J. de Pedro-Cuesta;

Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study J.E. Meca-Lallana; J.C. Álvarez-Cermeño; B. Casanova Estruch; G. Izquierdo Ayuso; R. Ortiz Castillo; A. Rodríguez-Antigüedad; C. Calles Hernández;

Relationship between inflammation and oxidative stress and its effect on multiple sclerosis E.J. Ramos-González; O.K. Bitzer-Quintero; G. Ortiz; J.J. Hernández-Cruz; L.J. Ramírez-Jirano;